Publikationen, an denen er mitarbeitet Luis Bujanda Fernández de Piérola (45)

2022

  1. TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation

    Journal of Hepatology, Vol. 77, Núm. 4, pp. 991-1004

2021

  1. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms

    Gut, Vol. 70, Núm. 7, pp. 1345-1361

2019

  1. Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage

    Gut, Vol. 68, Núm. 3, pp. 533-546

  2. Pterostilbene reduces liver steatosis and modifies hepatic fatty acid profile in obese rats

    Nutrients, Vol. 11, Núm. 5

2017

  1. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs

    United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260

  2. Pterostilbene-induced changes in gut microbiota composition in relation to obesity

    Molecular Nutrition and Food Research, Vol. 61, Núm. 1

  3. Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype

    Oncotarget, Vol. 8, Núm. 22, pp. 35848-35862

2016

  1. Effect of pravastatin on the survival of patients with advanced gastric cancer

    Oncotarget, Vol. 7, Núm. 4, pp. 4379-4384

  2. Effects of pterostilbene in brown adipose tissue from obese rats

    Journal of Physiology and Biochemistry, Vol. 73, Núm. 3, pp. 457-464

  3. Genetic variants associated with colorectal adenoma susceptibility

    PLoS ONE, Vol. 11, Núm. 4

  4. Influence of dopaminergic system genetic variation and lifestyle factors on excessive alcohol consumption

    Alcohol and Alcoholism, Vol. 51, Núm. 3, pp. 258-267

  5. Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects

    Journal of Physiology and Biochemistry, Vol. 72, Núm. 3, pp. 567-582

2015

  1. Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease

    International Journal of Cancer, Vol. 137, Núm. 6, pp. 1362-1373

  2. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease

    Journal of Hepatology, Vol. 63, Núm. 4, pp. 952-961

2014

  1. A simple and portable device for the quantification of TNF-α in human plasma by means of on-chip magnetic bead-based proximity ligation assay

    Biosensors and Bioelectronics, Vol. 54, pp. 499-505

  2. Effects of resveratrol and other polyphenols in hepatic steatosis

    World Journal of Gastroenterology, Vol. 20, Núm. 23, pp. 7366-7380

  3. Fecal immunochemical test accuracy in average-risk colorectal cancer screening

    World Journal of Gastroenterology, Vol. 20, Núm. 4, pp. 1038-1047

  4. Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases

    Gut, Vol. 63, Núm. 10, pp. 1658-1667

  5. Novel equation to determine the hepatic triglyceride concentration in humans by MRI: Diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery

    BMC Medicine, Vol. 12, Núm. 1

  6. Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests

    Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4